Next generation sequencing reveals the association of DRB3*02:02 with type 1 diabetes

Diabetes

Volumn 62, Issue 7, 2013, Pages 2618-2622

  Erlich, Henry A ^a   Valdes, Ana Maria ^b   McDevitt, Shana L ^c   Simen, Birgitte B ^d   Blake, Lisbeth A ^d   McGowan, Kim R ^d   Todd, John A ^e   Rich, Stephen S ^f   Noble, Janelle A ^c  

^a ROCHE MOLECULAR SYSTEMS   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d 454 Life Sciences A Roche Company   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DRB1 ANTIGEN; HLA DRB3 ANTIGEN; HLA DRB4 ANTIGEN; HLA DRB5 ANTIGEN; HLA DRB3*02:02:02 ANTIGEN; HLA-DRB3*02:02:02 ANTIGEN;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE MARKER; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENOMICS; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HLA SYSTEM; HOMOZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPLICATION STUDY; ADULT; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MALE;

ADULT; ALLELES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DRB3 CHAINS; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 84879551555     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1387     Document Type: Article

References (19)

1. Rich SS, Concannon P, Erlich H, et al. The Type 1 Diabetes Genetics Consortium. Ann N Y Acad Sci 2006;1079:1-8
2. Concannon P, Erlich HA, Julier C, et al.; Type 1 Diabetes Genetics Consortium. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005;54: 2995-3001
3. Barrett JC, Clayton DG, Concannon P, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009:41:703-707
4. Erlich H, Valdes AM, Noble J, et al.; Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008;57:1084-1092
5. Noble JA, Valdes AM, Varney MD, et al.; Type 1 Diabetes Genetics Consortium. HLA class 1 and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes 2010;59:2972-2979
6. Varney MD, Valdes AM, Carlson JA, et al.; Type 1 Diabetes Genetics Consortium. HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families. Diabetes 2010;59:2055-2062
7. Howson JM, Walker NM, Clayton D, Todd JA; Type 1 Diabetes Genetics Consortium. Confirmation of HLA class 2 independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab 2009;11(Suppl. 1):31-45
8. Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen class 1 B and C loci contribute to type 1 diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol 2005;66:301-313
9. Nejentsev S, Howson JM, Walker NM, et al.; Wellcome Trust Case Control Consortium. Localization of type 1 diabetes susceptibility to the MHC class 1 genes HLA-B and HLA-A. Nature 2007;450:887-892
10. Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, Erlich HA. The HLA class 1 A locus affects susceptibility to type 1 diabetes. Hum Immunol 2002;63:657-664
11. Noble JA, Valdes AM, Thomson G, Erlich HA. The HLA class 2 locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes 2000;49:121-125
12. Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005;437:376-380
13. Bentley G, Higuchi R, Hoglund B, et al. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 2009;74: 393-403
14. Holcomb CL, Höglund B, Anderson MW, et al. A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens 2011;77:206-217
15. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007;39:857-864
16. Thomson G. Mapping disease genes: family-based association studies. Am J Hum Genet 1995;57:487-498
17. Noble JA, Martin A, Valdes AM, et al. Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum Immunol 2008;69:291-300
18. Parry CS, Gorski J, Stern LJ. Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity. J Mol Biol 2007;371:435-446
19. Dai S, Crawford F, Marrack P, Kappler JW. The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles. Proc Natl Acad Sci USA 2008;105: 11893-11897